Evidence required to evaluate the use of bacteriologically confirmed asymptomatic tuberculosis disease as a primary endpoint in prevention of tuberculosis disease vaccine licensure trials
评估将细菌学确诊的无症状结核病作为结核病疫苗上市许可试验的主要终点所需的证据
期刊:Lancet Respiratory Medicine
影响因子:32.8
doi:10.1016/S2213-2600(25)00164-X
White, Richard G; Churchyard, Gavin J; Horton, Katherine C; Fiore-Gartland, Andrew; Behr, Marcel A; Clark, Rebecca A; Cobelens, Frank; Ernst, Joel D; Esmail, Hanif; Garcia-Basteiro, Alberto L; Hadinegoro, Sri Rezeki; Hanekom, Willem A; Hatherill, Mark; Hill, Philip C; Muloiwa, Rudzani; Pelzer, Puck T; Rangaka, Lele; Rees, Helen; Schrager, Lewis; Stanley, Margaret; Tufet, Marta; Wong, Emily B; Houben, Rein M G J